CYERA ACQUIRES ISRAELI AI GOVERNANCE STARTUP RYFT
AI DESK■ 1 MIN READ
MON, APR 27, 2026■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
Cyera has agreed to acquire Ryft, an Israeli startup specializing in automated data access and governance tools for enterprise AI, in a deal valued between $100M and $130M.
Ryft, founded in 2024, raised $8 million in funding before the acquisition. The startup has developed tools designed to automate data access controls and governance processes within AI environments, addressing a growing need as enterprises scale artificial intelligence deployments.
The acquisition signals Cyera's expansion into data governance automation for AI systems. As organizations accelerate AI adoption, managing data access and compliance has become increasingly critical.
Ryft's technology targets enterprises deploying AI at scale, where managing data access permissions and governance across multiple systems becomes complex. The deal underscores investor interest in infrastructure solutions that help enterprises safely and efficiently manage data in AI contexts.
Cyera, which focuses on data security and governance platforms, strengthens its portfolio with Ryft's automated governance capabilities. The transaction is expected to close, though specific terms beyond the valuation range remain undisclosed.
■ SOURCES
► Techmeme■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
YESTERDAY— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
YESTERDAY— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk